People · Operator

David E Friedman

Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Other

2
Companies
4
Filings
$20.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Genprex, Inc.BiotechnologySeries A$14.6M$52.7M2019
Oceanview Seacrest LLCOtherSeries A$6.0M$19.7M2025
Operator network

David E Friedman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David Friedman · 9 companies · 1 sharedDavid FriedmanJohn Rodney Varner · 2 companies · 1 sharedJohn Rodney VarnerBob Pearson · 1 companies · 1 sharedBob PearsonBob Rodney Pearson · 1 companies · 1 sharedBob Rodney PearsonDavid Rodney Friedman · 1 companies · 1 sharedDavid Rodney Frie…Julien M. Pham · 1 companies · 1 sharedJulien M. PhamJulien Rodney Pham · 1 companies · 1 sharedJulien Rodney PhamRobert Rodney Pearson · 1 companies · 1 sharedRobert Rodney Pea…Robert W. Pearson · 1 companies · 1 sharedRobert W. PearsonRyan M. Confer · 1 companies · 1 sharedRyan M. ConferRyan Rodney Confer · 1 companies · 1 sharedRyan Rodney ConferScott E Beberman · 1 companies · 1 sharedScott E BebermanGenprex, Inc. · $14.6M raisedGenprex, Inc.Oceanview Seacrest LLC · $6.0M raisedOceanview Seacrest LLCDavid E FriedmanDF
David E Friedman Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David E Friedman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David Friedman19
John Rodney Varner12
Bob Rodney Pearson11
David Rodney Friedman11
Scott E Beberman11
Robert W. Pearson11
Julien M. Pham11
Ryan M. Confer11
Julien Rodney Pham11
Robert Rodney Pearson11
Ryan Rodney Confer11
Bob Pearson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.